171 related articles for article (PubMed ID: 24661944)
1. Enhanced delivery of artemisinin and its analogues to cancer cells by their adducts with human serum transferrin.
Yang Y; Zhang X; Wang X; Zhao X; Ren T; Wang F; Yu B
Int J Pharm; 2014 Jun; 467(1-2):113-22. PubMed ID: 24661944
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Efficacy of Artemisinin Loaded in Transferrin-Conjugated Liposomes versus Stealth Liposomes against HCT-8 Colon Cancer Cells.
Leto I; Coronnello M; Righeschi C; Bergonzi MC; Mini E; Bilia AR
ChemMedChem; 2016 Aug; 11(16):1745-51. PubMed ID: 26999297
[TBL] [Abstract][Full Text] [Related]
3. Targeted Nanostructured Lipid Carrier for Brain Delivery of Artemisinin: Design, Preparation, Characterization, Optimization and Cell Toxicity.
Emami J; Yousefian H; Sadeghi H
J Pharm Pharm Sci; 2018; 21(1s):225s-241s. PubMed ID: 30266137
[TBL] [Abstract][Full Text] [Related]
4. Vanadium(V/IV)-Transferrin Binding Disrupts the Transferrin Cycle and Reduces Vanadium Uptake and Antiproliferative Activity in Human Lung Cancer Cells.
Levina A; Lay PA
Inorg Chem; 2020 Nov; 59(22):16143-16153. PubMed ID: 32578416
[TBL] [Abstract][Full Text] [Related]
5. Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA.
Shao Z; Shao J; Tan B; Guan S; Liu Z; Zhao Z; He F; Zhao J
Int J Nanomedicine; 2015; 10():1223-33. PubMed ID: 25709444
[TBL] [Abstract][Full Text] [Related]
6. Rapid screening of transferrin-binders in the flowers of Bauhinia blakeana Dunn by on-line high-performance liquid chromatography-diode-array detector-electrospray ionization-ion-trap-time-of-flight-mass spectrometry-transferrin-fluorescence detection system.
Liu M; Dong J; Lin Z; Niu Y; Zhang X; Jiang H; Guo N; Li W; Wang H; Chen S
J Chromatogr A; 2016 Jun; 1450():17-28. PubMed ID: 27178150
[TBL] [Abstract][Full Text] [Related]
7. A Novel Isoquinoline Derivative Anticancer Agent and Its Targeted Delivery to Tumor Cells Using Transferrin-Conjugated Liposomes.
Yang X; Yang S; Chai H; Yang Z; Lee RJ; Liao W; Teng L
PLoS One; 2015; 10(8):e0136649. PubMed ID: 26309138
[TBL] [Abstract][Full Text] [Related]
8. Constructing transferrin receptor targeted drug delivery system by using doxorubicin hydrochloride and vanadocene dichloride.
Zhang Y; Xiang J; Liu Y; Zhang X; Tang Y
Bioorg Med Chem Lett; 2011 Oct; 21(19):5982-6. PubMed ID: 21862329
[TBL] [Abstract][Full Text] [Related]
9. Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action.
Hou J; Wang D; Zhang R; Wang H
Clin Cancer Res; 2008 Sep; 14(17):5519-30. PubMed ID: 18765544
[TBL] [Abstract][Full Text] [Related]
10. Artesunate as an Anti-Cancer Agent Targets Stat-3 and Favorably Suppresses Hepatocellular Carcinoma.
Ilamathi M; Santhosh S; Sivaramakrishnan V
Curr Top Med Chem; 2016; 16(22):2453-63. PubMed ID: 26873192
[TBL] [Abstract][Full Text] [Related]
11. Synthetic strigolactone analogues reveal anti-cancer activities on hepatocellular carcinoma cells.
Hasan MN; Choudhry H; Razvi SS; Moselhy SS; Kumosani TA; Zamzami MA; Omran Z; Halwani MA; Al-Babili S; Abualnaja KO; Al-Malki AL; Alhosin M; Asami T
Bioorg Med Chem Lett; 2018 Apr; 28(6):1077-1083. PubMed ID: 29456109
[TBL] [Abstract][Full Text] [Related]
12. Farnesylthiosalicylic acid sensitizes hepatocarcinoma cells to artemisinin derivatives.
Wu L; Pang Y; Qin G; Xi G; Wu S; Wang X; Chen T
PLoS One; 2017; 12(2):e0171840. PubMed ID: 28182780
[TBL] [Abstract][Full Text] [Related]
13. Studies on the binding of fulvic acid with transferrin by spectroscopic analysis.
Zhang XF; Yang G; Dong Y; Zhao YQ; Sun XR; Chen L; Chen HB
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 137():1280-5. PubMed ID: 25305622
[TBL] [Abstract][Full Text] [Related]
14. Hydrotropic polymeric mixed micelles based on functional hyperbranched polyglycerol copolymers as hepatoma-targeting drug delivery system.
Zhang X; Zhang X; Yu P; Han Y; Li Y; Li C
J Pharm Sci; 2013 Jan; 102(1):145-53. PubMed ID: 23132353
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the pharmacokinetic profile of artesunate, artemether and their metabolites in sheep naturally infected with Fasciola hepatica.
Duthaler U; Huwyler J; Rinaldi L; Cringoli G; Keiser J
Vet Parasitol; 2012 May; 186(3-4):270-80. PubMed ID: 22206644
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of cytotoxicity of artemisinin toward cancer cells by transferrin-mediated carbon nanotubes nanoparticles.
Zhang H; Ji Y; Chen Q; Jiao X; Hou L; Zhu X; Zhang Z
J Drug Target; 2015; 23(6):552-67. PubMed ID: 25754587
[TBL] [Abstract][Full Text] [Related]
17. The biological characteristics of a novel camptothecin-artesunate conjugate.
Li Q; Wang W; Liu Y; Lian B; Zhu Q; Yao L; Liu T
Bioorg Med Chem Lett; 2015 Jan; 25(1):148-52. PubMed ID: 25453788
[TBL] [Abstract][Full Text] [Related]
18. Magnetic polycarbonate microspheres for tumor-targeted delivery of tumor necrosis factor.
Hu B; Du HJ; Yan GP; Zhuo RX; Wu Y; Fan CL
Drug Deliv; 2014 May; 21(3):204-12. PubMed ID: 24117028
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and in vitro evaluation of a series of novel polyrotaxane-based delivery system for artesunate.
Gong XS; Jiang RJ; Liao XL; Xie HD; Ma X; Gao CZ; Yang B; Zhao YL
Carbohydr Res; 2015 Aug; 412():7-14. PubMed ID: 25988495
[TBL] [Abstract][Full Text] [Related]
20. Transferrin-oligomers as potential carriers in anticancer drug delivery.
Lim CJ; Shen WC
Pharm Res; 2004 Nov; 21(11):1985-92. PubMed ID: 15587919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
